| 1 |
34893156 | Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives. | 2021 Jul-Dec |
1 |
| 2 |
31019568 | Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation. | 2019 |
9 |
| 3 |
25677905 | Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients. | 2015 Jul |
1 |
| 4 |
24970398 | Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers. | 2014 Sep |
1 |
| 5 |
23842854 | Significance of GSTP1 for predicting the prognosis and chemotherapeutic efficacy in esophageal squamous cell carcinoma. | 2013 Oct |
1 |
| 6 |
24137384 | Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients. | 2013 Sep |
1 |
| 7 |
21940361 | Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer. | 2012 Jan-Feb |
2 |
| 8 |
22320227 | GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. | 2012 May |
1 |
| 9 |
21133646 | Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy. | 2011 Feb |
3 |
| 10 |
21468552 | Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). | 2011 Mar-Apr |
1 |
| 11 |
20514304 | Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer. | 2010 Jun |
3 |
| 12 |
21029695 | [Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy]. | 2010 Jul |
2 |
| 13 |
20047135 | Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients. | 2009 Dec 12 |
2 |
| 14 |
17265526 | Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. | 2007 Mar 1 |
1 |
| 15 |
17322540 | Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. | 2007 Mar |
3 |
| 16 |
17551301 | Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese. | 2007 Jun |
1 |
| 17 |
16317430 | Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients. | 2006 Jan 30 |
1 |
| 18 |
15213713 | A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. | 2004 Jul 19 |
1 |
| 19 |
12072547 | Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. | 2002 Jun 19 |
2 |